Adlai Nortye Ltd. American Depositary Shares (ANL) Stock Analysis

Adlai Nortye Ltd. American Depositary Shares (ANL) is a publicly traded company in the HEALTHCARE sector. It trades at $12.03, carries a market capitalization of $774.71M. This page summarizes the public market data, fundamentals, and frequently asked questions for ANL, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Adlai Nortye Ltd. American Depositary Shares currently has a Bullish sentiment score of 0.28.

About Adlai Nortye Ltd. American Depositary Shares

Adlai Nortye Ltd. is a clinical-stage biotechnology company focused on the research and development of innovative cancer therapies, primarily targeting opportunities in the United States and Mainland China. Headquartered in Grand Cayman, the firm is committed to leveraging cutting-edge scientific methodologies to meet significant unmet medical needs in oncology. With a strong and diverse pipeline, Adlai Nortye is strategically positioned to make a meaningful impact in the cancer treatment lan...

GNG Research Analysis

GNG Research scores Adlai Nortye Ltd. American Depositary Shares (ANL) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ANL.

Frequently Asked Questions

Does ANL pay dividends?

Adlai Nortye Ltd. American Depositary Shares (ANL) does not currently pay a regular dividend.

What is ANL's market cap?

Adlai Nortye Ltd. American Depositary Shares (ANL) has a market capitalization of $774.71M with a current stock price of $12.03.